Skip to main content
TipRanks
Go Ultimate75% OFF

Chimeric Therapeutics Ltd. (CHM) Ratios

13 Followers

Chimeric Therapeutics Ltd. Ratios

AU:CHM's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, AU:CHM's free cash flow was increased by AU$6.94M and operating cash flow was AU$-6.94M. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio0.120.720.320.642.35
Quick Ratio0.120.720.320.642.44
Cash Ratio0.090.390.300.372.04
Solvency Ratio-2.09-0.48-0.90-1.49-1.63
Operating Cash Flow Ratio-1.21-0.50-0.75-1.11-1.46
Short-Term Operating Cash Flow Coverage-15.860.00-2.100.000.00
Net Current Asset ValueAU$ -7.98MAU$ -9.07MAU$ -9.58MAU$ -7.36MAU$ 12.00M
Leverage Ratios
Debt-to-Assets Ratio0.530.000.240.000.00
Debt-to-Equity Ratio-0.090.001.460.000.00
Debt-to-Capital Ratio-0.100.000.590.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio-0.1710.926.183.951.36
Debt Service Coverage Ratio-12.32-43.54-1.92-37.07-21.54
Interest Coverage Ratio0.00-71.61-37.10-38.10-22.77
Debt to Market Cap0.340.000.290.000.00
Interest Debt Per Share0.020.020.010.000.00
Net Debt to EBITDA0.010.63-0.050.191.35
Profitability Margins
Gross Profit Margin0.00%78.66%99.95%0.00%63.71%
EBIT Margin0.00%-254.72%-165.01%0.00%-556.82%
EBITDA Margin0.00%-228.71%-151.52%0.00%-520.53%
Operating Profit Margin0.00%-380.78%-165.06%0.00%-556.82%
Pretax Profit Margin0.00%-260.04%-218.30%0.00%-601.22%
Net Profit Margin0.00%-262.83%-168.01%0.00%-607.48%
Continuous Operations Profit Margin0.00%-262.83%-168.01%0.00%-607.48%
Net Income Per EBT100.12%101.07%76.96%85.45%101.04%
EBT Per EBIT224.85%68.29%132.25%102.86%107.97%
Return on Assets (ROA)-1470.94%-48.35%-82.04%-115.83%-45.58%
Return on Equity (ROE)243.56%-528.25%-507.27%-457.84%-61.85%
Return on Capital Employed (ROCE)109.80%-217.19%-237.81%-383.80%-56.35%
Return on Invested Capital (ROIC)120.57%-217.19%-108.02%-383.80%-56.35%
Return on Tangible Assets-1836.43%-99.09%-384.02%-275.80%-74.90%
Earnings Yield-937.98%-192.88%-100.06%-157.42%-48.01%
Efficiency Ratios
Receivables Turnover0.000.8786.130.000.98
Payables Turnover0.000.130.000.130.20
Inventory Turnover0.000.000.000.00-1.08
Fixed Asset Turnover0.000.0010887.090.00163.69
Asset Turnover0.000.180.490.000.08
Working Capital Turnover Ratio0.00-0.72-1.220.000.19
Cash Conversion Cycle0.00-2411.91-297913.94-2800.51-1775.97
Days of Sales Outstanding0.00418.584.240.00370.67
Days of Inventory Outstanding0.000.000.000.00-339.01
Days of Payables Outstanding0.002830.49297918.172800.511807.63
Operating Cycle0.00418.584.240.0031.66
Cash Flow Ratios
Operating Cash Flow Per Share-0.35-0.54-0.01-0.04-0.04
Free Cash Flow Per Share0.00-0.540.00-0.04-0.04
Dividend Paid and CapEx Coverage Ratio-1.00-7275729.00-1.00-145.43-24.45
Capital Expenditure Coverage Ratio-1.00-7275729.00-1.00-145.43-24.45
Operating Cash Flow Coverage Ratio-15.860.00-2.100.000.00
Operating Cash Flow to Sales Ratio0.00-1.83-1.010.00-5.03
Free Cash Flow Yield0.00%-134.54%0.08%-99.79%-41.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.11-0.52-1.00-0.64-2.08
Price-to-Sales (P/S) Ratio0.001.361.680.0012.65
Price-to-Book (P/B) Ratio-0.262.745.072.911.29
Price-to-Free Cash Flow (P/FCF) Ratio0.00-0.741238.23-1.00-2.42
Price-to-Operating Cash Flow Ratio-0.19-0.74-1.66-1.01-2.52
Price-to-Earnings Growth (PEG) Ratio0.010.010.01-0.020.44
Enterprise Value Multiple-0.230.04-1.16-0.39-1.08
Enterprise Value1.89M-349.78K13.06M11.09M14.73M
EV to EBITDA-0.230.04-1.16-0.39-1.08
EV to Sales0.00-0.091.750.005.63
EV to Free Cash Flow0.000.051291.77-0.68-1.08
EV to Operating Cash Flow-0.170.05-1.73-0.68-1.12
Tangible Book Value Per Share-0.25-0.67-0.01-0.020.03
Shareholders’ Equity Per Share-0.250.150.000.010.07
Tax and Other Ratios
Effective Tax Rate-0.00-0.010.23-0.00-0.01
Revenue Per Share0.000.290.010.000.01
Net Income Per Share-0.61-0.77-0.02-0.06-0.04
Tax Burden1.001.010.770.851.01
Interest Burden2.251.021.321.031.08
Research & Development to Revenue0.002.461.360.001.98
SG&A to Revenue0.001.781.210.003.34
Stock-Based Compensation to Revenue0.000.270.080.001.21
Income Quality0.570.700.600.630.83

Currency in AUD